AZD5672 Absolute Bioavailability Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of the study is to estimate the absolute bioavailability at steady state of 2 doses of AZD5672 (50 mg and 150 mg administered orally once daily)
Epistemonikos ID: e36a0ad4e9923f57562361f58cd630bcc2481b12
First added on: May 05, 2024